Mohamad Mohty, MD, PhD, Saint-Antoine Hospital, Paris, France, outlines some of the complications associated with both autologous and allogeneic hematopoietic cell transplantation (HSCT), including severe veno-occlusive disease (VOD) and thrombotic microangiopathy (TMA). This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).